Equities

PharmChem Inc

PCHM:PKC

PharmChem Inc

Actions
  • Price (USD)3.10
  • Today's Change0.05 / 1.64%
  • Shares traded8.80k
  • 1 Year change+21.57%
  • Beta0.7138
Data delayed at least 15 minutes, as of Nov 25 2024 18:43 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PharmChem Inc. is engaged in selling and distributing the PharmChek Sweat Patch Device (PharmChek). PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. PharmChek functions as a storage device where drugs are retained on the absorbent pad for detection in the laboratory. PharmChek detects Marijuana, Cocaine, Opiates, Amphetamine, Methamphetamine, PCP, Fentanyl, Oxycodone, Oxymorphone, Hydrocodone, and Hydromorphone. Its products include PharmChek Overlay, PharmChek Analysis Panels, and PharmChek for the Workplace. The PharmChek Overlay is made of the same polyurethane film as the PharmChek Sweat Patch and can be used to extend the wear time of the PharmChek Sweat patch. It is used in various industries, such as oil and gas field and marine environments, manufacturing, utilities, mining, transportation, and aerospace/aviation.

  • Revenue in USD (TTM)6.00m
  • Net income in USD1.27m
  • Incorporated2000
  • Employees170.00
  • Location
    PharmChem Inc2411 E. Loop 820 NFORT WORTH 76118United StatesUSA
  • Phone+1 (503) 227-2950
  • Fax+1 (503) 227-6874
  • Websitehttps://pharmchek.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Ontrak Inc11.24m-35.68m7.68m102.00--0.5402--0.683-10.55-10.553.023.370.5207--21.66110,186.30-123.82-54.80-228.86-73.3764.0053.50-237.77-71.95---2.270.4088---12.20-3.4439.08--99.58--
ATI Physical Therapy Inc741.86m-79.62m8.03m6.00k------0.0108-18.57-18.57174.1717.200.7625--8.02123,643.80-5.49---6.39--16.13---7.21----0.19050.8762--9.97--73.20------
Univec Inc-100.00bn-100.00bn8.07m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Healthlynked Corp3.32m-6.19m8.09m38.00------2.44-0.0222-0.02220.0119-0.00690.786215.8281.3287,385.27-146.48-119.37-966.37-332.2247.3355.81-186.32-119.260.4586-4.69-----2.3220.4357.08---12.94--
Pacific Health Care Organization Inc6.17m869.09k10.50m30.0012.090.921411.591.700.06780.06780.48120.890.5259--6.40205,557.707.417.297.937.8179.0382.7514.0913.28----0.00---2.00-3.7055.80-10.80-15.93--
Oncology Institute Inc378.93m-57.46m11.63m800.00--0.7516--0.0307-0.7706-0.77065.080.20491.9129.197.36473,666.30-35.34---44.12--14.1819.54-18.53-9.992.27-7.440.8553--28.4223.43-99,919.12--45.68--
Interpace Biosciences Inc44.89m4.89m11.72m108.002.41--2.270.2611.101.0610.13-2.533.1715.357.41415,675.9034.54-38.19---69.7360.4649.4410.88-41.010.52698.11----26.3112.93118.96--0.9184--
Aesthetic Medical Intl Hldg Grp Ltd(ADR)100.29m-6.68m11.96m1.29k--3.116.040.1192-0.1483-0.14832.210.08051.2920.8277.3677,987.70-9.06-23.36-35.45-48.5845.3955.32-7.02-23.720.2031-5.500.9581--1.86-2.1650.91--3.70--
Xcelerate Inc3.96m-296.19k12.11m1.00--8.70--3.06-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Streamline Health Solutions Inc20.30m-18.82m13.30m77.00--12.54--0.6551-0.3277-0.32770.34990.25110.4397--7.64263,636.40-40.77-22.06-56.63-31.6950.8649.96-92.72-54.55---4.460.4395---9.210.2057-64.31---11.72--
Psychemedics Corp.20.26m-3.00m13.76m116.00--2.53--0.6794-0.5142-0.51423.470.92381.69--5.12174,637.90-25.02-7.44-40.58-9.7038.3637.55-14.78-6.26---292.900.0969---12.45-12.33-283.21---33.32--
PharmChem Inc6.00m1.27m14.18m170.0011.184.5811.172.360.27270.27271.290.66611.677.238.04--35.37--44.59--64.09--21.17--4.45--0.00--3.50---16.95------
ProPhase Labs Inc12.75m-27.76m18.36m113.00--0.3848--1.44-1.50-1.500.68872.000.1393.740.3629112,858.40-30.250.9106-40.111.12-32.3850.32-217.640.93251.33-12.780.2837665.78-63.8127.59-190.90--86.46--
Concord Medical Services Hldgs Ltd (ADR)65.10m-52.30m19.28m727.00------0.2961-11.97-11.9714.90-67.990.074313.395.3589,549.30-10.23-9.49-111.95-39.24-17.13-15.06-137.67-134.560.4556-1.890.6369--13.8423.0039.21---6.88--
Elite Health Systems Inc0.00-1.18m20.86m2.00--5.70-----0.0938-0.09380.000.21060.00----0.00-45.56-14.62-49.63-19.89-------36.77----0.00------38.97------
Data as of Nov 25 2024. Currency figures normalised to PharmChem Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.